0001708138-20-000051.txt : 20200508 0001708138-20-000051.hdr.sgml : 20200508 20200508160337 ACCESSION NUMBER: 0001708138-20-000051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200506 FILED AS OF DATE: 20200508 DATE AS OF CHANGE: 20200508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tessier-Lavigne Marc CENTRAL INDEX KEY: 0001437435 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 20860481 MAIL ADDRESS: STREET 1: 1 DNA WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-05-06 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001437435 Tessier-Lavigne Marc 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2020-05-06 4 M 0 15000 177.82 A 16830 D Common Stock 2020-05-06 4 S 0 1025 562.65 D 15805 D Common Stock 2020-05-06 4 S 0 6375 563.45 D 9430 D Common Stock 2020-05-06 4 S 0 6600 564.45 D 2830 D Common Stock 2020-05-06 4 S 0 900 565.35 D 1930 D Common Stock 2020-05-06 4 S 0 100 566.01 D 1830 D Non-Qualified Stock Option (right to buy) 177.82 2020-05-06 4 M 0 15000 0.0 D 2023-01-02 Common Stock 15000 0 D Represents volume-weighted average price of sales of 1,025 shares of Company stock on May 6, 2020 at prices ranging from $562.12 to $562.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 6, 2020 at each separate price. Represents volume-weighted average price of sales of 6,375 shares of Company stock on May 6, 2020 at prices ranging from $563.00 to $563.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 6, 2020 at each separate price. Represents volume-weighted average price of sales of 6,600 shares of Company stock on May 6, 2020 at prices ranging from $564.00 to $564.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 6, 2020 at each separate price. Represents volume-weighted average price of sales of 900 shares of Company stock on May 6, 2020 at prices ranging from $565.00 to $565.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 6, 2020 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**Marc Trevor Tessier-Lavigne 2020-05-08